To include your compound in the COVID-19 Resource Center, submit it here.

Durata Therapeutics, RaQualia deal

Durata said that last December RaQualia granted the company

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE